The results of open observational trial DIAMOND

Código QR

The results of open observational trial DIAMOND

Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marina Vladimirovna Shestakova, Olga Konstantinovna Vikulova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2011
Materias:	type 2 diabetes mellitus hypoglycemia diamicron mb advance trial Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/e7749dfe1c75471fb9d3a9e4c0656bbc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
por: Olga Konstantinovna Vikulova
Publicado: (2012)

Glibenclamide therapy: pros and cons
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2011)

New indications for exenatide therapy of type 2 diabetes mellitus
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2010)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
por: Natalya Nikitichna Volevodz, et al.
Publicado: (2013)

Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)
por: Irina Evgen'evna Sapozhnikova, et al.
Publicado: (2010)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Comments on the Consensus statement of the American Diabetes Association and the European Association for the Studyof Diabetes on the medical management of hyperglycemia in type 2 diabetes
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009)

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
por: Vladimir Ivanovich Kudinov, et al.
Publicado: (2012)

Clinical and psychological aspects of hypoglycemia in patients with diabetes mellitus
por: Olga Georgievna Mel'nikova, et al.
Publicado: (2010)

Fear of hypoglycemia and its clinical significance: a case-control study
por: Elena Georgievna Starostina, et al.
Publicado: (2013)

ACE inhibitors as a risk factor for hypoglycemia
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2011)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB
por: Alexander Sergeevich Ametov, et al.
Publicado: (2009)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
por: Alla Vsevolodovna Rudakova
Publicado: (2011)

The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
por: Aleksey Vadimovich Zilov, et al.
Publicado: (2010)

National register of diabetes mellitus in Russian Federation.
por: Ivan Ivanovich Dedov, et al.
Publicado: (2015)

Renal allograft nephropathy in patient with type 1 diabetes mellitus
por: Ekaterina Vladimirovna Ivannikova, et al.
Publicado: (2012)

Can simple intensification of therapy with modern two-phase insulin help in type 2 diabetes when target glycemia failed to be achieved withbasal insulin? Results of subanalysis in the PRESENT study
por: Ch S Yang, et al.
Publicado: (2009)

Standards of Medical Care in Diabetes-2009 (American Diabetes Association): executive summary
por: Olga Konstantinovna Vikulova
Publicado: (2009)

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
por: Elena Valer'evna Biryukova, et al.
Publicado: (2012)

Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2016)

The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
por: Tat'yana Ivanovna Ionova, et al.
Publicado: (2015)

Issledovanie ONTARGET: Telmisartan ne ustupaet po effektivnosti ramiprilu u patsientov s vysokim riskom serdechno-sosudistykh oslozhneniy / sakharnym diabetom
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2008)

Arrhythmogenic effects of hypoglycemia
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2012)

Actual ambulatory care in patients with type 2 diabetes mellitus in Russian Federation according to open label prospectiveobservational study DIA-CONTROL
por: Marina Vladimirovna Shestakova
Publicado: (2011)

Efficacy and safety of treatment with human insulin analogues in daily management of insulin naive patients with type 2 diabetes mellitus: results of multicenter 52-week observational study A1chive
por: Marina Vladimirovna Shestakova
Publicado: (2012)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Sovremennye vozmozhnosti farmakoterapii sakharnogo diabeta 2 tipa pri pomoshchi analogov glyukagonopodobnogo peptida-1 (GPP-1)
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2007)

Novosti diabetologii
por: Olga Konstantinovna Vikulova
Publicado: (2007)

Novosti Diabetologii
por: Olga Konstantinovna Vikulova
Publicado: (2007)

A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
por: Marina Vladimirovna Shestakova
Publicado: (2012)

In Memorian: Harry Keen (3.09.1925?5.04.2013)
por: Zamira Tamrazovna Zuraeva, et al.
Publicado: (2013)

Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: resultsfrom a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 inroutine clinical practice
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2010)

Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
por: Elena V. Biryukova
Publicado: (2019)

Pre-clinical markers for diagnosis of diabetic nephropathy in patients with type 1 diabetes mellitus
por: Nadezhda Olegovna Lebedeva, et al.
Publicado: (2012)

Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
por: Olga D. Ostroumova, et al.
Publicado: (2020)

Prevalence of renal lesions in patients with type 1 and 2 diabetes mellitus in the Russian Federation
por: Oksana Vladimirovna Maslova, et al.
Publicado: (2009)

Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry
por: Ivan Ivanovich Dedov, et al.
Publicado: (2017)